Allen Keith B, Adams Joshua D, Badylak Stephen F, Garrett H Edward, Mouawad Nicolas J, Oweida Steven W, Parikshak Manesh, Sultan Parvez K
St. Luke's Hospital of Kansas City, St. Luke's Mid America Heart Institute, Kansas City, MO, United States.
Carilion Clinic Aortic and Endovascular Surgery, Roanoke, VA, United States.
Front Cardiovasc Med. 2021 Feb 11;8:631750. doi: 10.3389/fcvm.2021.631750. eCollection 2021.
Patch repair is the preferred method for arteriotomy closure following femoral or carotid endarterectomy. Choosing among available patch options remains a clinical challenge, as current evidence suggests roughly comparable outcomes between autologous grafts and synthetic and biologic materials. Biologic patches have potential advantages over other materials, including reduced risk for infection, mitigation of an excessive foreign body response, and the potential to remodel into healthy, vascularized tissue. Here we review the use of decellularized extracellular matrix (ECM) for cardiovascular applications, particularly endarterectomy repair, and the capacity of these materials to remodel into native, site-appropriate tissues. Also presented are data from two post-market observational studies of patients undergoing iliofemoral and carotid endarterectomy patch repair as well as one histologic case report in a challenging iliofemoral endarterectomy repair, all with the use of small intestine submucosa (SIS)-ECM. In alignment with previously reported studies, high patency was maintained, and adverse event rates were comparable to previously reported rates of patch angioplasty. Histologic analysis from one case identified constructive remodeling of the SIS-ECM, consistent with the histologic characteristics of the endarterectomized vessel. These clinical and histologic results align with the biologic potential described in the academic ECM literature. To our knowledge, this is the first histologic demonstration of SIS-ECM remodeling into site-appropriate vascular tissues following endarterectomy. Together, these findings support the safety and efficacy of SIS-ECM for patch repair of femoral and carotid arteriotomy.
补片修复是股动脉或颈动脉内膜切除术后动脉切开闭合的首选方法。在现有的补片选项中进行选择仍然是一项临床挑战,因为目前的证据表明自体移植物与合成材料和生物材料之间的结果大致相当。生物补片相对于其他材料具有潜在优势,包括降低感染风险、减轻过度的异物反应以及有可能重塑为健康的、血管化的组织。在此,我们回顾了脱细胞细胞外基质(ECM)在心血管应用中的使用,特别是内膜切除术修复,以及这些材料重塑为天然的、适合部位组织的能力。还展示了两项关于接受髂股动脉和颈动脉内膜切除术补片修复患者的上市后观察性研究的数据,以及一份具有挑战性的髂股动脉内膜切除术修复的组织学病例报告,所有这些都使用了小肠黏膜下层(SIS)-ECM。与先前报道的研究一致,保持了高通畅率,不良事件发生率与先前报道的补片血管成形术发生率相当。一例病例的组织学分析确定了SIS-ECM的建设性重塑,与内膜切除血管的组织学特征一致。这些临床和组织学结果与学术ECM文献中描述的生物学潜力相符。据我们所知,这是首次在内膜切除术后SIS-ECM重塑为适合部位血管组织的组织学证明。总之,这些发现支持了SIS-ECM用于股动脉和颈动脉切开补片修复的安全性和有效性。